Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BY 4.0Physics and Imaging in Radiation Oncology

Retrospective intrafraction motion verification using triggered kilovoltage images during bone metastases stereotactic body radiotherapy

Abstract

Background and purpose: Triggered kilovoltage images acquired during radiotherapy delivery remain underexploited for quantitative intrafraction motion analysis. This study aimed to develop and evaluate a retrospective workflow for intrafraction motion verification using triggered kilovoltage images during bone metastases stereotactic body radiotherapy. Materials and methods: Triggered kilovoltage images and corresponding treatment-planning data were retrospectively extracted from 49 patients treated in two radiotherapy centers. For each triggered image, a digitally reconstructed radiograph was generated from planning computed tomography dataset. After preprocessing, rigid in-plane registration between triggered images and digitally reconstructed radiographs was performed. The workflow was evaluated using phantom experiments with known physical displacements and patient datasets with simulated shifts, then applied to 8717 triggered images acquired during 183 treatment fractions. Results: Correct registration was obtained for 7105 images (81.5%), while 1612 images (18.5%) were classified as aberrant and excluded from motion analysis. After exclusion, the mean displacement vector magnitude was 1.2 ± 0.8 mm. Overall, 85% of measurements showed displacements ≤2 mm and 98% showed displacements ≤3 mm. Sustained displacement events exceeding 2 mm over three consecutive images were observed in 405 of 7105 images (5.7%) and in 46 of 159 analyzable fractions (28.9%). The mean computation time per image registration was 1699 ± 504 ms. Conclusions: Triggered kilovoltage images contain quantitative information that can support retrospective intrafraction motion assessment during bone metastases stereotactic body radiotherapy. This workflow may help identify fractions requiring further review and support offline quality assurance, although prospective validation is required before clinical implementation.

Related

  1. 473 Effect of nivolumab with or without relatlimab after stereotactic body radiotherapy in patients with advanced esophagogastric cancer
    Chen Hu, Valsamo Anagnostou, Gavin Pereira +11
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYImmunologyOncologyDOAJ
  2. Comparison of 2 stereotactic radiotherapy regimens for brain metastases: Is higher always better?
    Vincent Bourbonne, Moncef Morjani, Brieg Dissaux +7
    Neuro-Oncology AdvancesPeer-reviewedCC BY-NC 4.0Full textGeneral biologyHAL
  3. Stereotactic body radiation therapy enriches mediators of humoral immune activity in metastatic renal cell carcinoma.
    Nicholas J Salgia, Adil Khan, Yu Fujiwara +8
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textImmunologyOncologyEurope PMC
  4. SpiraMed: A Stereotactic Helix-based Therapy Delivery system for the Human Brain
    H. J. Bulstrode, A. Young, I. Huysman +22
    bioRxivPreprintAll rights reservedFull textSystems & synthetic biologybioRxiv
  5. The SWAN atlas: an open multimodal resource combining neuroimaging and high-resolution histology of the human brain in stereotactic space
    E. J. Lopes Alho, H. Friedrich, A. T. D. L. Alho +7
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv
BibTeX
@article{techer2026retrospective,
  title = {{Retrospective intrafraction motion verification using triggered kilovoltage images during bone metastases stereotactic body radiotherapy}},
  author = {Quentin Techer and Noé Grandgirard and Saturnin Sandjong and Vincent Marchesi and Paul Retif},
  journal = {Physics and Imaging in Radiation Oncology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.phro.2026.101054},
  url = {https://hal.science/hal-05779446v1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Retrospective intrafraction motion verification using triggered kilovoltage images during bone metastases stereotactic body radiotherapy
AU  - Quentin Techer
AU  - Noé Grandgirard
AU  - Saturnin Sandjong
AU  - Vincent Marchesi
AU  - Paul Retif
PY  - 2026
DA  - 2026/10/05
JO  - Physics and Imaging in Radiation Oncology
DO  - 10.1016/j.phro.2026.101054
UR  - https://hal.science/hal-05779446v1
AB  - Background and purpose: Triggered kilovoltage images acquired during radiotherapy delivery remain underexploited for quantitative intrafraction motion analysis. This study aimed to develop and evaluate a retrospective workflow for intrafraction motion verification using triggered kilovoltage images during bone metastases stereotactic body radiotherapy. Materials and methods: Triggered kilovoltage images and corresponding treatment-planning data were retrospectively extracted from 49 patients treated in two radiotherapy centers. For each triggered image, a digitally reconstructed radiograph was generated from planning computed tomography dataset. After preprocessing, rigid in-plane registration between triggered images and digitally reconstructed radiographs was performed. The workflow was evaluated using phantom experiments with known physical displacements and patient datasets with simulated shifts, then applied to 8717 triggered images acquired during 183 treatment fractions. Results: Correct registration was obtained for 7105 images (81.5%), while 1612 images (18.5%) were classified as aberrant and excluded from motion analysis. After exclusion, the mean displacement vector magnitude was 1.2 ± 0.8 mm. Overall, 85% of measurements showed displacements ≤2 mm and 98% showed displacements ≤3 mm. Sustained displacement events exceeding 2 mm over three consecutive images were observed in 405 of 7105 images (5.7%) and in 46 of 159 analyzable fractions (28.9%). The mean computation time per image registration was 1699 ± 504 ms. Conclusions: Triggered kilovoltage images contain quantitative information that can support retrospective intrafraction motion assessment during bone metastases stereotactic body radiotherapy. This workflow may help identify fractions requiring further review and support offline quality assurance, although prospective validation is required before clinical implementation.
SN  - 2405-6316
ER  -